Fortis Group Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$606K Hold
4,715
0.1% 173
2026
Q1
$515K Buy
4,715
+3
+0.1% +$346 0.09% 183
2025
Q4
$519K Buy
4,712
+3
+0.1% +$282 0.09% 203
2025
Q3
$405K Sell
4,709
-175
-4% -$14.4K 0.07% 172
2025
Q2
$382K Buy
4,884
+17
+0.3% +$1.35K 0.07% 172
2025
Q1
$437K Sell
4,867
-20
-0.4% -$1.87K 0.08% 143
2024
Q4
$486K Sell
4,887
-23
-0.5% -$2.37K 0.09% 134
2024
Q3
$558K Sell
4,910
-13
-0.3% -$1.54K 0.1% 115
2024
Q2
$609K Sell
4,923
-133
-3% -$17.1K 0.12% 109
2024
Q1
$667K Sell
5,056
-67
-1% -$8.26K 0.12% 114
2023
Q4
$545K Buy
5,123
+32
+0.6% +$3.32K 0.14% 67
2023
Q3
$541K Buy
5,091
+30
+0.6% +$3.23K 0.17% 62
2023
Q2
$584K Hold
5,061
0.16% 77
2023
Q1
$584K Buy
+5,061
New +$546K 0.18% 64
2020
Q3
$587K Buy
+7,425
New +$582K 0.11% 91

Other funds holding MRK

Fortis Group Advisors's MRK Position: Q2 2026 in Review

Fortis Group Advisors held its Merck (MRK) position steady in Q2 2026 at 4,715 shares worth $606K. The position accounts for 0.1% of the portfolio, ranked #173.

Fortis Group Advisors first reported a position in MRK in Q3 2020 and has held it in 15 quarters since. The position peaked at $667K in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Fortis Group Advisors held 4,715 shares of Merck worth $606K as of Q2 2026.
  • Fortis Group Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.1% of Fortis Group Advisors's portfolio in Q2 2026, its #173 holding.
  • Fortis Group Advisors first reported a position in Merck in Q3 2020 and has held it in 15 quarters since.
  • Fortis Group Advisors's Merck position peaked at $667K in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Fortis Group Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.